Previous slide
Next slide
The International Immunology Foundation sponsors research on advanced treatments for cancer, especially Immune Pheresis.
At the Lentz Treatment Center, we treat advanced cancers using Immune Pheresis, a breakthrough technology that can shrink and often eliminate malignant tumors more effectively than chemotherapy or radiation – without harmful side effects. The treatment is effective against a broad range of metastatic cancers. This innovative therapy is based on decades of scientific research into how tumors shield themselves from the immune system, and how this barrier can be removed. The treatment was awarded a CE mark – the EU equivalent of FDA approval – in 2008. We are currently accepting patients at our clinic in Prien, Germany.
POWERFUL YET GENTLE
Conventional treatment modalities like chemotherapy and radiation rarely work well for metastatic cancer. Even when they do induce tumor regression, side effects can be severe. Immune Pheresis is both more effective and significantly gentler than conventional treatments.
read more
BROADLY EFFECTIVE
Immune Pheresis has been shown to be effective against a broad range of metastatic cancer types. We have collected data from 100+ patients with 25 different tumor types treated in formal clinical trials and at our treatment center in Germany. Further clinical trials are being planned.
read more
BETTER FOR FAMILIES
Patients and their families like Immune Pheresis both because the treatment works well and has minimal side effects – so quality of life remains good. We have collected comments from patients and loved ones regarding their experience with Immune Pheresis.
read more
Medically Approved
Physicians appreciate that Immune Pheresis uses hospital-grade technology based on solid science, administered by a highly trained medical team. Here we have collected comments from doctors and researchers who have referred patients to us and seen the results first hand.
read more